Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| FEDERAL MOGU | FDML | 6.78% |
| SUMMER INFAN | SUMR | 6.63% |
| NEW ORIENTAL | EDU | 6.53% |
| NATUS MEDICA | BABY | 5.90% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Health Care REIT Inc. ( HCN - Analyst Report ) , a leading health care real estate investment trust (REIT) that operates senior housing and health care real estate, has recently completed its secondary offering of 13.8 million common shares at $58.75 each, including 1.8 million shares sold to underwriters to cover the over-allotment options.
Health Care REIT raised approximately $1.1 billion of gross proceeds from the offer. The company intends to utilize the proceeds to repay debt under its unsecured line of credit and other outstanding debt.
BofA Merrill Lynch, the investment banking and wealth management division of Bank of America Corporation ( BAC - Analyst Report ) ; Morgan Stanley ( MS - Analyst Report ) – a global financial services firm; Barclays Capital Inc., the investment banking division of Barclays PLC ( BCS - Snapshot Report ) ; J.P. Morgan Securities LLC, the investment banking division of JPMorgan Chase & Co. ( JPM - Analyst Report ) ; UBS Investment Bank, the investment banking division of UBS AG (UBS); and Wells Fargo Securities, part of Wells Fargo & Company ( WFC - Analyst Report ) acted as joint book-running managers for the offering.
Health Care REIT invests across the full spectrum of senior housing and healthcare real estate properties. Headquartered in Toledo, Ohio, the company also provides an extensive array of property management and development services.
Founded in 1970, the company was the first REIT to invest exclusively in healthcare facilities. Health Care REIT provides senior housing operators and healthcare systems with a single source for facility planning, design and turn-key development, property management, and monetization or expansion of existing real estate.
However, deep cuts in Medicare have been proposed over the next five years by reducing or freezing payments to skilled nursing facilities, hospitals, and other healthcare providers. With a large portion of revenues being determined by government payout rates, forces beyond the company’s control could negatively affect revenues and operator coverage ratios. Consequently, we maintain our ‘Neutral’ recommendation on Health Care REIT, which currently has a Zacks #3 Rank that indicates a short-term ‘Hold’ rating.
Read the full Analyst Report on JPM
Read the full Analyst Report on MS
Read the full Snapshot Report on BCS
Read the full Analyst Report on WFC
Read the full Analyst Report on HCN
Read the full Analyst Report on BAC